- Patent Title: Synthetic lung surfactant with enhanced stability and effectiveness
-
Application No.: US16063437Application Date: 2016-12-16
-
Publication No.: US10717777B2Publication Date: 2020-07-21
- Inventor: Frans J. Walther , Alan J. Waring , Larry M. Gordon
- Applicant: The Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center
- Applicant Address: US CA Torrance
- Assignee: The Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center
- Current Assignee: The Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center
- Current Assignee Address: US CA Torrance
- Agency: Sheppard Mullin Richter & Hampton LLP
- International Application: PCT/US2016/067317 WO 20161216
- International Announcement: WO2017/106742 WO 20170622
- Main IPC: C07K14/785
- IPC: C07K14/785 ; A61P11/00 ; A61K38/00

Abstract:
Peptides suitable for preparation of lung surfactants are described. Examples include one that include a first fragment comprising the amino acid sequence of XWLXRALIKRIQAZI (SEQ ID NO: 1) or a first amino acid sequence having at least 90% sequence identity to SEQ ID NO: 1 and a second fragment comprising the amino acid sequence of RZLPQLVXRLVLRXS (SEQ ID NO: 2) or a second amino acid sequence having at least 90% sequence identity to SEQ ID NO: 2, wherein X is any amino acid but at least one amino acid at the X positions is not cysteine, or Z is any amino acid but at least one amino acid at the Z positions is not methionine. Surfactants that contain such peptides, and related compositions, methods of preparing and using the compositions are also described.
Public/Granted literature
- US20190085053A1 SYNTHETIC LUNG SURFACTANT WITH ENHANCED STABILITY AND EFFECTIVENESS Public/Granted day:2019-03-21
Information query